Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2008
10/28/2008US7442704 Amide derivatives
10/28/2008US7442699 For treatment of rheumatoid arthritis, inflammatory or autoimmune condition, viral infection, cancer; 4-{[4-(4-chlorophenyl)pyrimidin-2-yl]amino}benzamide
10/28/2008US7442697 4-imidazolyl substituted pyrimidine derivatives with CDK inhibitory activity
10/28/2008US7442546 Method of modulating inflammatory response
10/28/2008US7442524 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia
10/28/2008US7442386 Synthesis and use of reagents for improved DNA lipofection and/or slow release prodrug and drug therapies
10/28/2008CA2546602C Monoacyl-substituted guanidines
10/28/2008CA2472107C Dibenzodiazepine derivates, their preparation and use
10/28/2008CA2448735C Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
10/28/2008CA2359027C S-nitrosothiols as agents for the treatment of circulatory dysfunctions
10/28/2008CA2358632C Drug combinations comprising (e)-7-¬4-(4-fluorophenyl)-6-isopropyl-2-¬methyl(methylsulfonyl)amino|pyrimidin-5-yl|(3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
10/23/2008WO2008128086A1 Ranolazine for enhancing insulin secretion
10/23/2008WO2008127603A2 Transient receptor potential vanilloid 1 and uses thereof
10/23/2008WO2008127591A2 Pyrimidinedione derivatives and use thereof
10/23/2008WO2008127180A1 Use of selected lactic acid bacteria for reducing atherosclerosis
10/23/2008WO2008126920A1 Remedy for diabetes
10/23/2008WO2008126901A1 Nitrogen-containing heterocyclic compound and pharmaceutical composition containing the same
10/23/2008WO2008126831A1 Atropisomer of pyrrole derivative
10/23/2008WO2008126772A1 Therapeutic agent for hypertension
10/23/2008WO2008126752A1 Skin-lightening agent containing equol compound as active ingredient
10/23/2008WO2008126732A1 Fused bicyclic heteroaryl derivatives
10/23/2008WO2008126693A1 Remedy and diagnostic for mitochondrial dysfunction brain disease
10/23/2008WO2008126094A1 Treatment of myocarditis using fts
10/23/2008WO2008125800A2 Mmp activated vascular disrupting agents
10/23/2008WO2008125725A1 Modified routes of lipid metabolism, measuring oxidized ldl after fat loading.
10/23/2008WO2008125724A1 Estimation and biological consequences of oxidative metabolism
10/23/2008WO2008125714A1 Use of l-carnitine for treating arterial hypertension
10/23/2008WO2008125279A2 Atrial-radiofrequency catheter ablation mediated targeting of mesenchymal stromal cells
10/23/2008WO2008125215A1 Bicyclic and heterobicyclic derivatives, processes for preparing them and their uses
10/23/2008WO2008125014A1 Urea compounds, preparation methods and pharmaceutical uses thereof
10/23/2008WO2008125006A1 Preparation processes for ivabradine hydrochloride and its stable crystalline form
10/23/2008WO2008124974A1 Use of human urinary kallidinogenase for manufacturing a medicament for the treatment and/or prevention of hypertension complicated by cerebral infarction
10/23/2008WO2008124857A2 Plant extract, and use thereof
10/23/2008WO2008040000A3 Soluble epoxide hydrolase inhibitors
10/23/2008WO2008006607A3 Pharmaceutical and nutraceutical products comprising vitamin k2
10/23/2008WO2007080325A8 Fgf-receptor agonist dimeric compounds
10/23/2008WO2006118488A3 Processed sunflower black seed oil and use thereof in pharamac eut i cal and cosmetic compositions
10/23/2008US20080262221 (PYRIDO/THIENO)-[f]-OXAZEPINE-5-ONE DERIVATIVES
10/23/2008US20080262205 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease
10/23/2008US20080262108 Screening for active modulators with binding affinity of Carboxyl Ester Lipase(CEL)(cholesterol esterase) to receptors for the prevention/treatment of atherosclerosis; immunohistochemistry; screening/biological/; reducing the retention of atherogenic lipoproteins in atherogenesis; mechanism of action
10/23/2008US20080262096 Squaric Acid Derivatives
10/23/2008US20080262086 Substituted anthranilic acids
10/23/2008US20080262069 carvedilol phosphate salts, which include novel crystalline forms of carvedilol dihydrogen phosphate (i.e., dihydrogen phosphate salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy) ethyl]amino]-2-propanol) and/or carvedilol hydrogen phosphate, etc.), and/or solvates , compositions containing compounds
10/23/2008US20080262063 Novel inhibitors of glutaminyl cyclase
10/23/2008US20080262062 disease treatable with PARP modulators by identifying a level of PARP in a plurality of samples from a population, making a decision regarding identifying the disease treatable by the PARP modulators wherein the decision is made based on the level of PARP
10/23/2008US20080262059 AT 1-antagonist vaisertan or a pharmaceutically acceptable salt thereof; and(ii) a NEP inhibitor or a pharmaceutically acceptable salt thereof and optionally a pharmaceutically acceptable carrier and to a method for the treatment or prevention of a condition or diseaseselected from hypertension
10/23/2008US20080262050 Organic Compounds
10/23/2008US20080262045 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12
10/23/2008US20080262039 Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process For Making Them, and Use Thereof For Treating Pain and Other Conditions
10/23/2008US20080262028 Imidazole derivatives as inhibitors of tafia
10/23/2008US20080262016 Isoquinoline derivatives and methods of use thereof
10/23/2008US20080262009 dissolving an amount of compound and acetic acid as a mixture, in one or more solvents; and precipitating one crystalline polymorph of the compound as the acetate salt from the mixture
10/23/2008US20080262006 Selective endothelin type-a antagonists
10/23/2008US20080261976 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
10/23/2008US20080261960 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents
10/23/2008US20080261959 Novel crystalline forms of (S)-N-(1-Carboxy-2-methyl-prop-1-y)-N-pentanoyl-N[2'-(1H-tetrazol-5-yl)bi-phenyl-4-ylmethyl]-amine
10/23/2008US20080261958 Combination of Organic Compounds
10/23/2008US20080261948 Ligands for G-Protein Coupled Receptors
10/23/2008US20080261947 Poly(ADP-ribose)polymerase inhibitor; ischemic diseases, cerebral infarction, antiretroviral, sensitizer for anticancer therapy, immunosuppressant; 5,6,7,8-tetrahydrophthalazin-1(2H)-one compounds; 2,3,4,6-tetrahydropyrido[2,3-d]pyridazin-5(1H)-one compounds
10/23/2008US20080261943 Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use
10/23/2008US20080261942 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
10/23/2008US20080261941 Inhibitors of fatty acid amide hydrolase; N-pyridin-3-yl-4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzylidene)piperidine-1-carboxamide; elevate brain anandamide levels; pain, urinary incontinence, cognitive disorders, anxiety, depression, sleeping, eating, movement disorders, glaucoma, psoriasis
10/23/2008US20080261928 Determining whether there is an elevation in marinobufagenin in blood-derived or urine-derived specimens and, if such elevation does exist, concluding that preeclampsia exists; administered orally or by injection; high speed, accurate treatment; reducing blood pressure; hypotensive agents
10/23/2008US20080261926 Pharmaceutical Calcimimetics
10/23/2008US20080261920 Treat diseases related to biological function of trace amine associated receptors; depression, anxiety, bipolar, attention deficit hyperactivity, psychosis; includes all racemic mixtures, isomers; (S)-4-(2-chloro-phenyl)-4,5-dihydro-oxazol-2-ylamine
10/23/2008US20080261892 Angiogenesis; neovascularization; lyophilization; kits
10/23/2008US20080261877 Albumin Fusion Proteins
10/23/2008US20080261875 Method For Treating Cardiovascular Disease
10/23/2008US20080261871 Y2/Y4 Selective Receptor Agonists for Therapeutic Interventions
10/23/2008US20080261869 For treating bacterial and viral infections; kits
10/23/2008US20080261865 Oxidized Lipids and Uses Thereof in the Treatment of Inflammatory Diseases and Disorders
10/23/2008US20080261224 PGC-1Beta, A Novel PGC-1 Homologue and Uses Therefor
10/23/2008US20080260877 Plant extracts and compositions for reducing blood lipid levels
10/23/2008US20080260874 Nutraceutical; crushed maca aqueous ethanol extract; food and beverage product, perfume and cosmetic, or pharmaceutical; ameliorate cold sensation, numbness, pains and other skin symptoms, as well as frostbites, chilblains and chaps
10/23/2008US20080260868 Folate based composition for neurological and cognitive applications
10/23/2008US20080260839 Stable, high porosity silicon microparticle aerosol carriers derived from semiconductor p+ wafers; resorbable and/or photoluminescent
10/23/2008US20080260797 Methods of treating disease with nitric oxide (no)-releasing polymers and soluble no-releasing nitrosamines
10/23/2008US20080260752 Prevention and reduction of blood loss
10/23/2008US20080260746 Erythropoietin polypeptide for use in treatment and prevention of viral, skin, nervous system, autoimmune, cardiovascular, kidney, cell proliferative and cardiovascular disorders
10/23/2008US20080260733 Humanized collagen antibodies and related methods
10/23/2008US20080260713 Neukinase, A Downstream protein of neuregulin
10/23/2008US20080260709 Probiotic yeast broth for reducing blood or hepatic cholesterol level and preventing and/or treating cell proliferative and atherogenic disorders
10/23/2008US20080260704 Using myocytes, cardiomyocytes and/or striated muscle cells in stem cell culture to treat cardiomyopathy; tissue engineering and repair; regenerative medicine
10/23/2008US20080260688 Imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea
10/23/2008US20080260681 Using poloxamer; therapy for cardiovascular disorders, muscular dystrophy, apoptosis and antiischemic agents
10/23/2008US20080260679 Methods and compositions for treatment of ion imbalances
10/23/2008US20080260645 Cold pressed vegetable oils; hypotensive agents; anticholesterol agents
10/23/2008DE102007018662A1 Oxazolidinone zur Behandlung und Prophylaxe von pulmonaler Hypertonie Oxazolidinones for the treatment and prophylaxis of pulmonary hypertension
10/23/2008CA2683915A1 Pyrimidinedione derivatives and methods of use thereof
10/23/2008CA2683912A1 Use of selected lactic acid bacteria for reducing atherosclerosis
10/23/2008CA2683793A1 Combination anticoagulant therapy with a compound that acts as a factor xa inhibitor
10/23/2008CA2683089A1 Benzimidazole derivatives and imidazopyridine derivatives with glucose lowering effect
10/23/2008CA2682855A1 Therapeutic agent and diagnostic agent for mitochondrial dysfunction brain diseases
10/23/2008CA2681444A1 Ranolazine for enhancing insulin secretion
10/22/2008EP1983055A1 Albumin fusion proteins
10/22/2008EP1982990A1 Cytokine receptor common gamma chain like
10/22/2008EP1982986A1 Pyrrolopyridazinone compound
10/22/2008EP1982984A2 Tricyclic thrombin receptor antagonists
10/22/2008EP1982981A1 Process for production of lasofoxifene or analogue thereof
10/22/2008EP1982732A2 Factor VII or VIIA-like molecules
1 ... 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 ... 1595